NERATINI

Clinical trials for NERATINI explained in plain language.

Never miss a new study

Get alerted when new NERATINI trials appear

Sign up with your email to follow new studies for NERATINI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to stop breast cancer return in High-Risk patients

Disease control Recruiting now

This Phase 3 trial tests whether a combination of trastuzumab and neratinib works better than the standard trastuzumab and pertuzumab for women with a certain type of breast cancer (HER2-positive, hormone receptor-positive) who still have small amounts of cancer after initial che…

Matched conditions: NERATINI

Phase: PHASE3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control

Last updated Jun 27, 2026 07:51 UTC

NERATINI

Get alerted when new NERATINI trials appear

New drug combo aims to stop breast cancer return in High-Risk patients